AJP - Heart AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (November 30, 2007). doi:10.1152/ajpheart.00811.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/2/H1086    most recent
00811.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heiss, C.
Right arrow Articles by Springer, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heiss, C.
Right arrow Articles by Springer, M. L.
Submitted on July 12, 2007
Accepted on November 30, 2007

In Vivo Measurement of Flow-Mediated Vasodilation in Living Rats using High Resolution Ultrasound

Christian Heiss1, Richard E. Sievers2, Nicolas Amabile1, Tony Y Momma3, Qiumei Chen2, Shobha Natarajan1, Yerem Yeghiazarians1, and Matthew L. Springer1*

1 Division of Cardiology, UCSF, San Francisco, California, United States
2 Cardiology, UCSF, San Francisco, California, United States
3 Nutrition, UC Davis, Davis, California, United States

* To whom correspondence should be addressed. E-mail: matt.springer{at}ucsf.edu.

In humans, endothelial vasodilator function serves as a surrogate marker for cardiovascular health and is measured as changes in conduit artery diameter after temporary ischemia (flow-mediated dilation; FMD). Here, we present an FMD-related approach to study femoral artery (FA) vasodilation in anesthetized rats. Diameter and Doppler-flow were monitored in the FA. Using high-resolution ultrasound (35 MHz) and automated analysis software, we detected dose-dependent vasodilation using established endothelium-independent (IV nitroglycerin EC50=3.3x10-6 mol/L, peak 21{Delta}% (SD 4)) and endothelium-dependent (IA acetylcholine EC50=1.3x10-6 mol/L, peak 27{Delta}% (SD 4)) pharmacologic vasodilators. Wall shear stress (WSS) induced by intra-aortic injection of adenosine and infusion of saline at increasing rates (1.5-4.5 mL/min) led to vasodilation at 1-2 min. Transient hindlimb ischemia by common iliac occlusion (5 min) led to reactive hyperemia with flow-velocity and WSS increase and was followed by FA dilation (16{Delta}% (SD 2)), the latter of which was completely abolished by NO-synthase (NOS) inhibition with L-NMMA (1{Delta}% (SD 2)). FMD was significantly reduced in adult 20-24 week old animals as compared to 9-10 week old animals, consistent with age-dependent endothelial dysfunction (16{Delta}% (SD 3) vs 10{Delta}% (SD 3), p<0.05). While FMD was completely NOS-dependent in 9-10 week old animals, NOS-dependent mechanisms accounted for only half of the FMD in 20-24 week old animals, with the remainder being blocked by charybdotoxin and apamin, suggesting contribution of endothelium-derived-hyperpolarizing-factor. To our knowledge, this is the first integrative physiologic model to reproducibly study FMD of conduit arteries in living rats.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.